Orbimed Advisors as of Sept. 30, 2015
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 130 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 5.2 | $513M | 8.7M | 59.20 | |
Hca Holdings (HCA) | 4.6 | $452M | 5.8M | 77.36 | |
Amgen (AMGN) | 4.2 | $417M | 3.0M | 138.32 | |
Boston Scientific Corporation (BSX) | 4.0 | $394M | 24M | 16.41 | |
Allergan | 4.0 | $392M | 1.4M | 271.81 | |
Celgene Corporation | 3.9 | $389M | 3.6M | 108.17 | |
Biogen Idec (BIIB) | 3.9 | $382M | 1.3M | 291.81 | |
Abbvie (ABBV) | 3.8 | $378M | 6.9M | 54.41 | |
Alexion Pharmaceuticals | 3.5 | $348M | 2.2M | 156.39 | |
Incyte Corporation (INCY) | 3.0 | $302M | 2.7M | 110.33 | |
Impax Laboratories | 2.4 | $235M | 6.7M | 35.21 | |
Regeneron Pharmaceuticals (REGN) | 2.3 | $227M | 488k | 465.14 | |
Molina Healthcare (MOH) | 2.2 | $223M | 3.2M | 68.85 | |
Health Net | 2.2 | $220M | 3.6M | 60.22 | |
Gilead Sciences (GILD) | 2.2 | $215M | 2.2M | 98.19 | |
Illumina (ILMN) | 2.0 | $202M | 1.2M | 175.82 | |
Cooper Companies | 2.0 | $194M | 1.3M | 148.86 | |
Intercept Pharmaceuticals In | 1.9 | $186M | 1.1M | 165.86 | |
Thermo Fisher Scientific (TMO) | 1.7 | $167M | 1.4M | 122.28 | |
Wright Medical | 1.7 | $166M | 8.1M | 20.39 | |
Neurocrine Biosciences (NBIX) | 1.5 | $152M | 3.8M | 39.79 | |
Shire | 1.4 | $136M | 664k | 205.23 | |
Relypsa | 1.4 | $137M | 7.4M | 18.51 | |
McKesson Corporation (MCK) | 1.3 | $130M | 700k | 185.03 | |
Teva Pharmaceutical Industries (TEVA) | 1.2 | $124M | 2.2M | 56.46 | |
Agilent Technologies Inc C ommon (A) | 1.2 | $122M | 3.5M | 34.33 | |
Pfizer (PFE) | 1.2 | $118M | 3.8M | 31.41 | |
Ironwood Pharmaceuticals (IRWD) | 1.2 | $117M | 11M | 10.42 | |
Community Health Systems (CYH) | 1.2 | $116M | 2.7M | 42.77 | |
Insys Therapeutics | 1.2 | $116M | 4.1M | 28.46 | |
Intuitive Surgical (ISRG) | 1.1 | $110M | 239k | 459.58 | |
Express Scripts Holding | 1.1 | $109M | 1.3M | 80.96 | |
Eli Lilly & Co. (LLY) | 1.1 | $107M | 1.3M | 83.69 | |
Magellan Health Services | 1.0 | $102M | 1.8M | 55.43 | |
Clovis Oncology | 1.0 | $102M | 1.1M | 91.96 | |
Bluebird Bio (BLUE) | 1.0 | $102M | 1.2M | 85.55 | |
Allergan Plc pfd conv ser a | 1.0 | $98M | 104k | 943.46 | |
Puma Biotechnology (PBYI) | 0.9 | $90M | 1.2M | 75.36 | |
Ophthotech | 0.8 | $78M | 1.9M | 40.52 | |
Mallinckrodt Pub | 0.8 | $75M | 1.2M | 63.94 | |
NuVasive | 0.7 | $72M | 1.5M | 48.22 | |
Glaukos (GKOS) | 0.7 | $70M | 2.9M | 24.19 | |
Tesaro | 0.7 | $70M | 1.7M | 40.10 | |
Affymetrix | 0.7 | $64M | 7.5M | 8.54 | |
Dynavax Technologies (DVAX) | 0.6 | $61M | 2.5M | 24.54 | |
Insmed (INSM) | 0.6 | $58M | 3.1M | 18.57 | |
Array BioPharma | 0.5 | $46M | 10M | 4.56 | |
Portola Pharmaceuticals | 0.4 | $42M | 985k | 42.62 | |
Otonomy | 0.4 | $40M | 2.3M | 17.81 | |
Pronai Therapeutics | 0.4 | $41M | 2.0M | 20.52 | |
Medtronic (MDT) | 0.4 | $39M | 588k | 66.94 | |
Chimerix (CMRX) | 0.4 | $39M | 1.0M | 38.20 | |
Infinity Pharmaceuticals (INFIQ) | 0.4 | $37M | 4.4M | 8.45 | |
Loxo Oncology | 0.4 | $38M | 2.2M | 17.48 | |
Achillion Pharmaceuticals | 0.4 | $36M | 5.2M | 6.91 | |
ImmunoGen | 0.3 | $35M | 3.6M | 9.60 | |
Gw Pharmaceuticals Plc ads | 0.3 | $35M | 377k | 91.37 | |
EXACT Sciences Corporation (EXAS) | 0.3 | $32M | 1.8M | 17.99 | |
Sientra | 0.3 | $30M | 3.0M | 10.15 | |
Cerus Corporation (CERS) | 0.3 | $30M | 6.5M | 4.54 | |
Valeant Pharmaceuticals Int | 0.3 | $29M | 165k | 178.38 | |
Affimed Therapeutics B V | 0.3 | $28M | 4.6M | 6.17 | |
Johnson & Johnson (JNJ) | 0.3 | $27M | 292k | 93.35 | |
UnitedHealth (UNH) | 0.3 | $28M | 238k | 116.01 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $27M | 1.8M | 14.57 | |
Newlink Genetics Corporation | 0.3 | $26M | 712k | 35.84 | |
Forward Pharma A/s | 0.2 | $23M | 961k | 23.56 | |
Dyax | 0.2 | $21M | 1.1M | 19.09 | |
Merck & Co (MRK) | 0.2 | $21M | 415k | 49.39 | |
Galapagos Nv- (GLPG) | 0.2 | $21M | 513k | 40.71 | |
Aduro Biotech | 0.2 | $21M | 1.1M | 19.37 | |
BioMarin Pharmaceutical (BMRN) | 0.2 | $20M | 188k | 105.32 | |
XenoPort | 0.2 | $20M | 5.8M | 3.47 | |
Zimmer Holdings (ZBH) | 0.2 | $20M | 212k | 93.93 | |
D Fluidigm Corp Del (LAB) | 0.2 | $20M | 2.4M | 8.11 | |
Cynapsus Therapeutics | 0.2 | $18M | 1.1M | 16.17 | |
Stryker Corporation (SYK) | 0.2 | $18M | 186k | 94.10 | |
eHealth (EHTH) | 0.2 | $17M | 1.3M | 12.81 | |
Jazz Pharmaceuticals (JAZZ) | 0.1 | $15M | 115k | 132.81 | |
Sinovac Biotech (SVA) | 0.1 | $14M | 2.7M | 5.08 | |
Xencor (XNCR) | 0.1 | $14M | 1.1M | 12.23 | |
Natera (NTRA) | 0.1 | $14M | 1.3M | 10.85 | |
Assembly Biosciences | 0.1 | $13M | 1.4M | 9.56 | |
Pieris Pharmaceuticals | 0.1 | $13M | 7.3M | 1.83 | |
Nabriva Therapeutics | 0.1 | $13M | 1.3M | 9.50 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $12M | 115k | 104.14 | |
Synergy Pharmaceuticals | 0.1 | $12M | 2.3M | 5.30 | |
Baxter International (BAX) | 0.1 | $11M | 319k | 32.85 | |
Cardinal Health (CAH) | 0.1 | $11M | 146k | 76.82 | |
Ensign (ENSG) | 0.1 | $11M | 248k | 42.63 | |
WellCare Health Plans | 0.1 | $9.8M | 114k | 86.18 | |
Abbott Laboratories (ABT) | 0.1 | $8.5M | 211k | 40.22 | |
Incyte Corp. note 1.250 11/1 | 0.1 | $9.4M | 4.3M | 2.21 | |
Incyte Corp note 0.375%11/1 | 0.1 | $9.0M | 4.3M | 2.11 | |
Cellectis S A (CLLS) | 0.1 | $9.2M | 350k | 26.36 | |
Baxalta Incorporated | 0.1 | $9.0M | 285k | 31.51 | |
Mirati Therapeutics | 0.1 | $8.3M | 240k | 34.42 | |
Connecture | 0.1 | $7.9M | 1.7M | 4.56 | |
Aetna | 0.1 | $7.3M | 67k | 109.40 | |
Redhill Biopharma Ltd cmn | 0.1 | $7.3M | 565k | 12.91 | |
Advaxis | 0.1 | $6.5M | 637k | 10.23 | |
Macrogenics (MGNX) | 0.1 | $6.8M | 317k | 21.42 | |
Fluidigm Corporation convertible cor | 0.1 | $7.2M | 10M | 0.72 | |
Seres Therapeutics (MCRB) | 0.1 | $7.3M | 247k | 29.64 | |
Immunomedics | 0.1 | $5.7M | 3.3M | 1.72 | |
Anacor Pharmaceuticals In | 0.1 | $6.3M | 53k | 117.71 | |
Lion Biotechnologies | 0.1 | $5.9M | 1.0M | 5.76 | |
Sage Therapeutics (SAGE) | 0.1 | $6.3M | 150k | 42.32 | |
Roka Bioscience | 0.1 | $6.3M | 3.2M | 1.95 | |
Alimera Sciences | 0.0 | $3.8M | 1.7M | 2.21 | |
Fate Therapeutics (FATE) | 0.0 | $3.7M | 693k | 5.33 | |
Horizon Pharma | 0.0 | $4.0M | 204k | 19.82 | |
Vitae Pharmaceuticals | 0.0 | $4.0M | 362k | 11.01 | |
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $3.6M | 5.2M | 0.70 | |
Inotek Pharmaceuticals | 0.0 | $4.0M | 425k | 9.40 | |
Ascendis Pharma A S (ASND) | 0.0 | $3.9M | 222k | 17.70 | |
Biotie Therapies Corp. ads | 0.0 | $3.5M | 269k | 13.09 | |
Pernix Therapeutics Holdings | 0.0 | $3.4M | 1.1M | 3.16 | |
Ocular Therapeutix (OCUL) | 0.0 | $2.9M | 209k | 14.06 | |
Invitae (NVTAQ) | 0.0 | $3.3M | 457k | 7.22 | |
Medigus | 0.0 | $2.7M | 600k | 4.48 | |
Biolinerx Ltd-spons | 0.0 | $1.6M | 1.0M | 1.53 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $2.1M | 177k | 11.97 | |
Xtant Med Holdings | 0.0 | $1.5M | 475k | 3.26 | |
MannKind Corporation | 0.0 | $1.4M | 450k | 3.21 | |
Qlt | 0.0 | $1.3M | 500k | 2.66 | |
Amarin Corporation (AMRN) | 0.0 | $676k | 350k | 1.93 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $655k | 500k | 1.31 | |
Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $655k | 500k | 1.31 | |
Cogentix Medical | 0.0 | $1.2M | 991k | 1.24 |